PredxBio

The Spatial Medicine Company™

Experience SpaceIQ® Live at SITC 2026Book a meeting at Booth 713 →

New website coming soon

From tissue biology to oncology decisions

Spatial Medicine connects how cells are organized and interact within tissue to decisions about treatment, patient selection, and drug development.

Tissue organization and connected spatial patternsA conceptual illustration of cells arranged into tissue neighborhoods, connected to a simplified spatial network. TISSUESPATIAL BIOLOGYDECISIONS

Pioneering Spatial Medicine

SpaceIQ® connects tissue architecture with the biology of response and resistance, helping teams prioritize therapies, refine patient selection, and advance biomarkers toward clinical use.

POWERED BY SPACEIQ®

From complex tissue data to evidence that guides drug development

Four connected capabilities bring tissue quality, spatial biology, and explainable AI into your oncology program.

01 · MEASURE

Quantitative QC

Identify image and biological artifacts before they shape downstream analysis.

02 · DISCOVER

Tissue States

Reveal cellular neighborhoods and tissue organization linked to the biology of response and resistance.

03 · EXPLAIN

Interpretable Models

Connect spatial patterns with outcomes and examine the biology behind the signal.

04 · TRANSLATE

Clinical Compression

Distill rich spatial discoveries into focused biomarker candidates for clinical assay development and validation.

WORK WITH PREDXBIO

Move your oncology program forward

Guide clinical development

Inform patient stratification, investigate response and resistance, and prioritize therapeutic strategies through focused projects with our scientific team.

Advance biomarkers toward the clinic

Co-develop focused biomarker signatures from spatial discoveries, with a path toward clinical assay development and validation.

Integrate SpaceIQ® into your workflow

Bring tissue QC, spatial analysis, and decision intelligence into your workflow through software access, scientific support, and integration.

For research projects, partnerships, and investor inquiries: [email protected]

FROM PREDXBIO ON LINKEDIN

Follow what’s next

Selected science, ideas, and perspectives from our team.

Follow PredxBio on LinkedIn

See all updates on LinkedIn

Subscribe to our Newsletter

* indicates required





Registration

Join us for the Spatial Intelligence Summit. Complimentary and paid registration categories are listed below – hurry, early bird pricing ends on September 30.

We received your request! One of our team members will be in touch as soon as possible.

Submit your Resume

Download Whitepaper

Download Whitepaper

B. Dusty Majumdar, PhD

CHIEF EXECUTIVE OFFICER

B. Dusty Majumdar, PhD  is a seasoned leader in Precision Healthcare with more than 20 years of experience in building and successfully launching innovative technologies across oncology, multi-omics, Real-World Evidence (RWE). diagnostic imaging and liquid biopsy platforms leveraging some of the industry’s most advanced AI platforms, genomic and clinical simulations (digital twins), and emerging medical imaging technologies. Dr. Majumdar’s experience includes leading strategy and marketing as the Chief Marketing Officer (CMO) at IBM and multiple commercial and technical leadership roles at GE Healthcare, Exact Sciences and 3M. He has also led the commercial and strategic functions in a range of start-ups in the healthcare/biopharma space over the last few years.  Dr. Majumdar is a widely respected global leader in the healthcare industry and holds a Ph.D. from the University of Texas at Austin and a bachelor’s degree from the Indian Institute of Technology (IIT), Kharagpur.  He has authored several peer-reviewed scientific publications and holds multiple patents.

Joe Camaratta

Sr. VP Business Development

Joe Camaratta specializes in medical technology innovation and commercialization, taking products from concept to clinical adoption. He held executive positions for GE Healthcare and Siemens Healthcare and built businesses in medical imaging, cardiology, and oncology. He founded and led two early stage medical technology companies that apply artificial intelligence to improve clinical decision-making.

Joe holds a Master of Science degree in Computer Science from Rutgers University and a Bachelor of Science degree in Computer Science from Drexel University. He currently serves as an advisor to the Entreprenuerial Investing Program of the Crohn’s & Colitis Foundation, and the University Science Center QED Program focused on commercialization of academic innovations

Bruce Campbell, MS

VP Software Engineering

Bruce leads the software engineering and quality assurance teams at PredxBio. As the VP of Software Engineering, he is responsible for analytical infrastructure, product development and the commercialization of machine learning, image processing, and computational biology algorithms. Prior to joining PredxBio, Bruce was at IBM and Xylem in global Director of Data Science roles. He has over 20 years of experience in digital pathology algorithms and is highly motivated to deliver care through digital and computational pathology. He has multiple successful FDA 510k device applications, and multiple CLIA certified algorithms deployed in clinical practice.

Bruce holds a BS in Physics and MS in Applied Mathematics from the University of Rochester, an MS in Statistics from North Carolina State University, and is currently pursuing graduate mathematics studies at The Ohio State University. Bruce loves the outdoors. You can find him hiking and rock climbing in Appalachia.